XML 59 R40.htm IDEA: XBRL DOCUMENT v3.19.3
EQUITY-BASED COMPENSATION - Summary of stock option activity (Details) - USD ($)
9 Months Ended
Sep. 10, 2019
Sep. 30, 2019
Dec. 31, 2018
Shares      
Shares outstanding, Beginning Balance (shares)   0  
Shares granted (shares) 101,082 101,082  
Options from Flex Pharma (shares)   90,279  
Shares exercised (shares)   0  
Shares forfeited (shares)   0  
Shares expired (shares)   0  
Shares outstanding, Ending Balance (shares)   191,361  
Shares exercisable (shares)   91,059  
Weighted-Average Exercise Price      
Shares outstanding, weighted-average exercise price, Beginning Balance (in usd per share)   $ 0  
Shares granted, weighted-average exercise price (in usd per share)   8.00  
Options from Flex Pharma, weighted-average exercise price (in usd per share)   102.22  
Shares exercised, weighted-average exercise price (in usd per share)   0  
Shares forfeited, weighted-average exercise price (in usd per share)   0  
Shares expired, weighted-average exercise price (in usd per share)   0  
Shares outstanding, weighted-average exercise price, Ending Balance (in usd per share)   52.45  
Shares exercisable, weighted-average exercise price (in usd per share)   $ 101.41  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Outstanding, weighted-average remaining contractual term   5 years 10 months 28 days  
Exercisable, weighted-average remaining contractual term   1 year 5 months 12 days  
Outstanding, aggregate intrinsic value   $ 0 $ 0
Exercisable, aggregate intrinsic value   $ 0